Midori Nakayama holds two of her felt artworks.
10:30 JST, June 6, 2025
CHIKUSEI, Ibaraki — Stretching their bodies or strolling, many of the cats and dogs created by artist Midori Nakayama have lively expressions and look as if they are about to move. Visitors to the Shimodate Museum of Art in Chikusei, Ibaraki Prefecture, can get a close look at her felt art masterpieces at an ongoing exhibition.
About 500 pieces — mainly cats and dogs — created with wool felt are on display.
Now a leading felt artist in Japan, Nakayama majored in Japanese painting at an art university. In 2001, she came across felt art and started creating works modeled after her family dog. She then began receiving orders from pet owners who saw her work and now creates custom items. The exhibition featuring her artworks has been held across the nation.
At the museum, the space under the high ceiling has been put to use to showcase her artworks.
“I hope visitors can enjoy the display of cats holding umbrellas coming down from the ceiling,” she said.
The exhibition runs through June 29. The museum is closed on Mondays. Admission is ¥700 for adults.
Top Articles in Culture
-
Director Naomi Kawase’s New Film Explores Heart Transplants in Japan, Production Involved Real Patients, Families
-
Exhibition Featuring Yoshiharu Tsuge’s Manga World Underway in Chofu, Tokyo; Unique, Surreal Works Draw Steady Crowds
-
Traditional Japanese Silk Hakama Tradition Preserved by Sole Weaver in Sendai
-
2 Unpublished Early Novellas by Japan’s Kenzaburo Oe Discovered, Show Budding Promise of Future Nobel Prize-Winning Author
-
Beckoning Cats Get Makeover to Fit Modern Lifestyles with Sleek Designs to Match with Any Kind of Space
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

